PIK3CG and cancer: As such, the expected multiple interactions of aspirin and its metabolite salicylate with various complex networks of signaling pathways involving PI3K imply that numerous interactions must be considered to unravel the mechanisms of aspirin-mediated inhibition of PIK3CA-mutated cancer.